Cancer Radiotherapie

Papers
(The TQCC of Cancer Radiotherapie is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Stereotactic magnetic resonance imaging-guided radiotherapy for intracardiac metastases: A case report91
Issue Contents63
Nuclear protein in testis (NUT) midline carcinoma of the larynx: A rare case report of a paediatric patient and literature review34
Radiotherapy and pregnancy28
Hypofractionated radiotherapy in the management of rectal tumours26
Outcomes of adjuvant lymph node field radiotherapy and immunotherapy for stage III melanoma22
Extra- and intracranial schwannomas treated with fractionated stereotactic irradiation: Results of a retrospective, multicentric study20
Role of autophagy in modulating tumor cell radiosensitivity: Exploring pharmacological interventions for glioblastoma multiforme treatment19
Radiation therapy in the thoracic region: Radio-induced cardiovascular disease, cardiac delineation and sparing, cardiac dose constraints, and cardiac implantable electronic devices17
Neoadjuvant treatment of pancreatic adenocarcinoma: Chemoradiation or stereotactic body radiation therapy?16
Effets secondaires endocriniens de la radiothérapie : diagnostic, prévention et traitements14
Quality of weight loss during chemoradioherapy in patients with nasopharyngeal cancers14
Surface-guided radiotherapy overview: Technical aspects and clinical applications14
Management of metallic implants in radiotherapy13
Role of radiotherapy in the management of rare solid thoracic tumors of the adults13
Contribution of chemotherapy in immunoradiotherapy combinations13
Can we predict the cardiac benefit of deep inspiration breath hold for left breast and regional nodal irradiation?13
Prognostic factors for 495 nonoperative esophageal squamous cancer patients receiving IMRT plus chemotherapy: A retrospective analysis11
Use of nanoparticles in radiation oncology11
Assurance qualité de la radiothérapie en recherche clinique11
Editorial Board11
Le rôle de la protonthérapie dans les cancers de l’oesophage10
Radiotherapy of bone metastases10
Issue Contents10
Role of radiotherapy in the management of bladder cancer: Recommendations of the French society for radiation oncology10
Études qui changent les pratiques en oncoradiothérapie digestive10
Stereotactic body radiation therapy for liver metastases in oligometastatic disease10
Analyse de l’impact des résultats du séquençage de nouvelle génération chez les patients atteints de glioblastome9
Relecteurs 2021 pour Cancer Radiothérapie9
Radiotherapy of skin cancers9
Role of radiotherapy in the management of testicular cancer: Recommendations from the French society for radiation oncology9
Étude de faisabilité : l’utilisation de l’imagerie médicale en éducation thérapeutique en radiothérapie9
La radiothérapie stéréotaxique au Maroc : état des lieux et compatibilité technologique avec les exigences minimales des recommandations internationales de bonne pratique9
Evolution of radiation oncology training in France: Over 20 years of the role of the Société française des jeunes radiothérapeutes oncologues (SFjRO, the French society of young radiation oncologists)9
Radiation therapy: Regulatory framework and constraints9
Editorial9
Dosimetric comparison of advanced radiotherapy planning techniques for hippocampal sparing whole brain radiotherapy9
First experiences with an adaptive pelvic radiotherapy system: Analysis of treatment times and learning curve8
Réirradiation des récidives de carcinomes mammaires8
Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a single-center early experience8
Thoracic reirradiation of recurrent non-small cell lung carcinoma: A comprehensive review8
Comprehensive commissioning and quality assurance validation of Ethos™ therapy8
Stereotactic body radiation therapy for bone oligometastases8
Editorial Board8
Editorial Board7
Breast cancer in a transgender man and hypofractionated radiotherapy: A case report and review of literature7
Gestion des doses liées à l’imagerie de positionnement en radiothérapie7
News in magnetic resonance imaging use for radiation oncology7
Metastasis-directed radiotherapy for non-small cell lung cancer failured under TKI: A case report and literature review7
Dosimetric comparison of different intensity-modulated radiotherapy techniques for whole-breast irradiation of right-breast cancer7
Quality control of postoperative radiotherapy for non-small cell lung cancer: A study of mediastinal shift7
Qualitative evaluation of automatic liver segmentation in computed tomography images for clinical use in radiation therapy7
Brachytherapy: An emblematic example of extreme hypofractionated regimen7
Fibrose pulmonaire radio-induite : nouvelles cibles pour demain7
Combinaison de la radiothérapie interne vectorisée et de la radiothérapie externe7
Comprehensive analysis of uveal mucosa-associated lymphoid tissue lymphomas: Epidemiological insights and radiotherapy utilization from the Surveillance, Epidemiology and End Results database7
Radiotherapy for nasopharyngeal cancer: 2025 update7
Radiotherapy of cervical cancer7
Role of radiotherapy in the management of brain oligometastases7
Radiotherapy of benign intracranial tumours7
Long-term cardiac mortality in patients treated with radiation for gastric mucosa-associated lymphoid tissue lymphoma6
Tumeurs rares du sein6
Issue Contents6
Hypofractionated radiotherapy for invasive squamous cell carcinoma of the scalp in the elderly: Efficacy and tolerance, preliminary results6
Insights on the carbon footprint of radiotherapy in France6
Fractionated Stereotactic Radiation Therapy for Pituitary Adenomas: An alternative escalating protocol of hypofractionated stereotactic radiotherapy delivering 35 Gy in 5 fractions6
Comments on “Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study”6
Radiation therapist, a key player in radiotherapy research5
Voxel-wise analysis: A powerful tool to predict radio-induced toxicity and potentially perform personalised planning in radiotherapy5
Spontaneous resolution of intracranial hypertension following radiotherapy for posterior parasagittal meningioma: About two cases and review of the literature5
Radiotherapy for cancers of the oesophagus, cardia and stomach5
Guide for paediatric radiotherapy procedures: 2025 update5
Hypofractionated radiotherapy for pancreatic cancer: What role in 2025?5
Editorial Board5
Breast cancer tumour board: Which patients are eligible for radiotherapy de-escalation or omission?5
Editorial Board5
Hypofractionated radiotherapy in the management of bladder cancer5
Role of radiotherapy in the management of vulvar cancer: Recommendations of the French society for radiation oncology5
Limites de la définition des contraintes de dose pour les organes à risque spécifiques à la radiothérapie stéréotaxique5
Application of intraoperative radiotherapy for malignant glioma5
Failure patterns analysis of three-dimensional radiotherapy for stage IV non-small cell lung cancer primary tumours5
Preoperative ultra-hypofractionation radiotherapy in extremity/trunk wall soft tissue sarcoma — A meta-analysis of prospective studies4
Adaptive radiotherapy4
Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?4
Acute toxicity in patients with high-risk prostate cancer treated with stereotactic body radiation, with irradiation to the prostate and pelvic nodes4
Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy4
Radiotherapy for hypopharynx cancers: 2025 update4
Radiotherapy and pregnancy: 2025 update4
Transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma: Long-term results of RTF3 regimen4
Role of stereotactic radiotherapy in the management of small-cell lung cancer4
Issue Contents4
Multicriteria optimization of radiation therapy: Towards empowerment and standardization of reverse planning for head and neck squamous cell carcinoma4
Defining the potential for sexual structures-sparing for prostate cancer external beam radiotherapy: A dosimetric study4
Radiotherapy and CDK inhibitors: Opportunities and risks4
Patterns of relapse after postoperative radiotherapy in patients with oral cavity cancer and a flap4
Radiation therapy of the primary tumour and/or metastases of digestive metastatic cancers4
Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancer4
Issue Contents4
Role of radiotherapy in the treatment of primary vaginal cancer: Recommendations of the French society for radiation oncology4
Is hypofractionated radiotherapy used to treat soft tissue sarcomas? Assessment of practices using the NETSARC network4
The QuADRANT project: Enhancing quality and safety in radiological procedures through clinical audit3
Radiotherapy for rare primary brain tumors3
Preoperative stereotactic radiotherapy for the management of brain metastases3
Application of deep learning to auto-delineation of target volumes and organs at risk in radiotherapy3
Head and neck cancers volume reduction: should we reduce our prophylactic node radiation to spare the antitumor immune response?3
Moderate versus ultra-hypofractionated locoregional breast radiotherapy: Results of a retrospective study during the covid-19 era3
Kinetics of plasma cell-free DNA as a prospective biomarker to predict the prognosis and radiotherapy effect of esophageal cancer3
Postoperative radiotherapy in prostate cancer: When and how? – An update review3
Stereotactic body radiotherapy for mediastinal lymph node with CyberKnife®: Efficacy and toxicity3
Complementary therapies: What are we talking about?3
Pathologie hématologique : le modèle le plus abouti de désescalade en radiothérapie3
Prognostic significance of different lymph node staging systems in patients with resectable, node-positive, stage III, non-small cell lung cancer: Identifying the optimal classification for enhanced p3
Management of cervical lymphadenopathies of unknown primary cancer3
Interactions endothélium vasculaire – cellules immunitaires : un point de contrôle clef des lésions digestives radio-induites3
Permanent alopecia after radiotherapy of primary brain tumours: The most influential factors3
Orbital follicular lymphoma with large cell component treated with low-dose radiotherapy: A case report and review of literature3
Issue Contents3
Radiotherapy in the management of synchronous metastatic lung cancer3
Aspects biologiques, précliniques et cliniques de l’association de radiothérapie et d’inhibiteur de CDK 4/63
Editorial Board3
Que faut-il pour faire de la radiothérapie adaptative « online » ?3
The role of radiation therapy for de novo metastatic bladder and renal cancers3
Radiotherapy for oral cavity cancers3
Radiotherapy: Beyond cancer…3
Health-related quality of life and cognitive failures in patients with lower-grade gliomas treated with radiotherapy3
Evaluating ChatGPT to test its robustness as an interactive information database of radiation oncology and to assess its responses to common queries from radiotherapy patients: A single institution in3
Contents3
External radiotherapy for prostatic cancers3
Place de la radiothérapie stéréotaxique pour les cancers bronchiques non à petites cellules de stade I opérables3
Artificial intelligence solution to accelerate the acquisition of MRI images: Impact on the therapeutic care in oncology in radiology and radiotherapy departments3
Editorial Board3
Dose-escalation in prostate cancer: Results of randomized trials3
Cancer de l’endomètre de stade localisé : la perspective d’une désescalade thérapeutique guidée par la classification moléculaire3
Editorial Board3
Hypofractionated postoperative stereotactic radiotherapy for large resected brain metastases3
Influence de l’immunothérapie sur le choix du traitement des cancers bronchiques non à petites cellules de stade I : point de vue de l’oncologue radiothérapeute3
Observation of the efficacy and safety of concurrent intensity-modulated radiation with 5-fluorouracil and oxaliplatin for locally advanced nasopharyngeal carcinoma3
What effective technique to differentiate radiation brain necrosis from a tumor progression in patients treated with radiation: A monocentric retrospective study combining the MRI TRAMs technique and 3
What is the future of uterovaginal brachytherapy in private practice in France?3
Issue Contents3
0.11908411979675